The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells

This publication has 26 references indexed in Scilit:

• High numbers of granzyme B/CD8‐positive tumour‐infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent
  The Journal of Pathology, 2002
• Modulators of Inflammation Use Nuclear Factor-κB and Activator Protein-1 Sites to Induce the Caspase-1 and Granzyme B Inhibitor, Proteinase Inhibitor 9
  Journal of Biological Chemistry, 2002
• Regulation of mast-cell and basophil function and survival by IgE
  Nature Reviews Immunology, 2002
• Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
  Blood, 2002
• Nucleocytoplasmic Distribution of the Ovalbumin Serpin PI-9 Requires a Nonconventional Nuclear Import Pathway and the Export Factor Crm1
  Molecular and Cellular Biology, 2001
• The Granzyme B Inhibitor, PI-9, Is Present in Endothelial and Mesothelial Cells, Suggesting That It Protects Bystander Cells during Immune Responses
  Cellular Immunology, 2001
• A kinetic analysis of the expression of mast cell protease mRNA in the intestines ofNippostrongylus brasiliensis-infected rats
  European Journal of Immunology, 1998
• Expression, Purification, and Inhibitory Properties of Human Proteinase Inhibitor 8
  Biochemistry, 1997
• A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes
  Journal of Biological Chemistry, 1996
• The ovalbumin family of serpin proteins
  FEBS Letters, 1993